US3924641A - Bi-phasic current stimulation system - Google Patents
Bi-phasic current stimulation system Download PDFInfo
- Publication number
- US3924641A US3924641A US498740A US49874074A US3924641A US 3924641 A US3924641 A US 3924641A US 498740 A US498740 A US 498740A US 49874074 A US49874074 A US 49874074A US 3924641 A US3924641 A US 3924641A
- Authority
- US
- United States
- Prior art keywords
- switches
- paths
- voltage terminal
- switch
- electrodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
Definitions
- ABSTRACT [22] Filed: Aug. 19, 1974
- a circuit for producing current-controlled bi-phasic [21] PP No: 498,740 pulses to stimulate living tissue includes two conducting paths connected in parallel between high and low 52 US. Cl 128/419 PG; 128/421 W terminals with each of the csnducting PathS 51 1m. (:1. A61N l/36 havmg first and seem! switches in Series 5 Field f Search 128/42O, 421, 422 423, therein. The intersections of the respective first and 128/419 13, 419 C 419 E 419 G, 419 PG, second switches in each of the paths define output ter- 9 R minals across which bi-phasic pulses are produced.
- These output terminals include electrode members for 5 References Cited electrically attaching therlrli tto living tissutes.
- lrgerfcolrlinectin circuits connectt e irst switch 0 eac 0 t e UNITED STATES PATENTS condu ting paths with the second switch of the other LaVCZZT) conducting to respectively open and close the 2 a 419 P6 second switches in response to the first switches of op- 3:727:616 41973 1.5112122: izizi i i: posite paths being operfed and closed A digital 3,835,865 9/1974 Bowers 128/419 PG gramme alternately dm'es one of the first swltches Canada 128/419 R open and the other closed.
- Current controlling valves are connected in the paths between the low voltage terminal and the output terminals to selectively control current flow through the electrodes.
- This invention relates broadly to the art of electronic stimulators and more particularly to devices for generating current controlled, bi-phasic pulses to stimulate areas of the brain, nerves, or other organs.
- Brain stimulation is also applied in efforts to fight other disorders associated with the brain.
- electrical stimulation is also widely used to restore proper functioning of various organs such as hearts, lungs, or bladders in cases where the control of these organs is disturbed because of disease, injury, or other causes.
- pulses of one polarity are used for stimulation, electro/chemical effects tend to create unfavorable interactions between electrodes and tissues.
- Many researchers therefore, prefer stimulation pulses in both polarities, such as with a negative pulse, followed immediately by a positive pulse, preferably each being of equal magnitude and duration.
- Another object of this invention is to provide a circuit for generating bi-phasic, current-controlled pulses with current amplitudes of both negative and positive portions thereof being proportional to an applied control voltage.
- Still another object of this invention is to provide a current controlled, bi-phasic or mono-phasic pulse generator whose output impedance is high enough to allow the use of its stimulation electrodes for measuring the response to stimulation, e.g. brain stimulation, EEG recordings and the like.
- Still another object of this invention is to provide a circuit for generating bi-phasic or mono-phasic current controlled pulses, the characteristics of which are controlled by a programmer.
- first switch of the first path is interconnected to the second switch of the second path, and vice versa, to assure that the first and second switches of opposite paths are opened and closed together.
- a driving device alternately drives the first switch of the first path on or closed," and the first switch of the second path off,
- the driving mechanism measures the time period that the switches are in open and closed positions, Electronic valves are located in each of the first and second paths between the first voltage terminal and the output terminals to selectively control current flow to the electrodes.
- FIG. 1 is a schematic diagram of a current controlled, bi-phasis pulse generator employing principles of this invention.
- FIG. 2 is a diagrammatic representation of an output pulse of the bi-phasic pulse generator of FIG. 1.
- the preferred embodiment of the pulse generator of this invention comprises two first transistor switches 10 and 12, two second transistor switches 14 'and 16, a pair of current control valve devices 18 and 20, a digital programmer 22 and a control voltage generator 24.
- the pulse generator is energized by a +20 volts, positive voltage terminal 26 and a -20 volts, negative voltage terminal 28 and forms two parallel connected, main conducting paths 30 and 32 between these voltage terminals. In practice, a single 40 volt source could be used.
- the first transistor switches 10 and 12 comprise PNP transistors Q1 and Q2 and 22K control resistors 34 and 36.
- the second transistor switches 14 and 16 comprise NPN transistors Q3 and Q4 and K control resistors 38 and 40,
- the interconnection between the positive voltage terminal 26 and the base of the transistor Q1 via the resistor 34 holds transistor O1 in an off state when transistor Q4 is off and no current can flow through resistor 40.
- transistor O4 When transistor O4 is on, a current path is established from the positive voltage terminal 26 through both the Q1 base-to-emitter junction, and the resistor 34, the resistor 40, and the transistor O4 to the negative voltage terminal 28, thereby placing transistor O1 in an on state.
- the first and second current control valve devices 18 and 20 respectively comprise NPN transistors Q5 and Q6 and series resistors 42 and 44.
- the switching transistors Q1, Q2, Q3, and Q4 are chosen to operate, for practical purposes, in an on-off fashion while the current control transistors Q5 and Q6 are chosen to operate in a gradual manner for regulating current flow.
- Electrodes 46 and 48 which are adapted to be electricallyattached to living tissue, are respectively electrically connected to the main conducting paths 30 and 32 between the transistor switch 10- and the first current control valve device 18 and between'the transistor switch 12 and thesecond current control valve device
- the digital programmer 22 is connected to the bases of the switching transistors Q3 and Q4 and selectively provides gating signals to these transistors.
- the digital programmer 22 also drives the control voltage generator 24 which, in turn, selectively produces steady-state control voltages at the bases of the first and second current control transistors Q and Q6.
- Diodes 50 and 52 prevent excess reverse voltages from occurring between the bases and emitters of the current control transistors Q5 and Q6.
- the electrodes 46 and 48 are connected to living tissue, such as nerves or other organs, either directly or indirectly.
- the digital programmer 22 gates the switching transistor Q3 on and the switching transistor Q4 off for a time period of T1 and then gates the switching transistor Q4 on and switching transistor Q3 off for an identical time period T2.
- the switching transistor Q3 is turned off so that the voltage appearing at the base of the switching transistor Q2 rises to the voltage of the positive voltage terminal 26, which, in turn, turns off the switching transistor Q2.
- the electrode 46 is no longer connected to the high voltage terminal 26.
- the switching transistor Q4 is turned on by the digital programmer 22 so that the voltage at the base of the switching transistor Q1 rises to turn on this transistor.
- the electrode 48 is now in communication with the positive voltage terminal 26.
- the other electrode 46 is now in communication with the negative voltage terminal 28 via the second current control device 20, the diode 52 and the switching transistor Q4.
- the polarities, and current flow, of the electrodes 46 and 48 have been reversed.
- the digital programmer Before and after the time periods T1 and T2, the digital programmer does not place either the third or fourth switching transistors Q3 and Q4 in on modes of operation so that neither of the electrodes 46 and 48 are connected to the positive and negative voltage terminals 26 and 28.
- the output signal appearing at electrodes 46 and 48 before, after, and during the time periods T1 and T2 can be graphically represented as shown in FIG. 2.
- control voltage generator 24 provides steady-state control voltages ranging from 1.4 to 5 volts. It should be understood that the magnitude of a selected control voltage determines the magnitudes of current signals applied by the electrodes 46 and 48 to living tissue.
- the duration of the pulses can be accurately controlled by the digital programmer 22.
- the electrodes 46 and 48 can be used for recording purposes.
- a bi-phasic pulse generator for producing pulses to stimulate living tissue comprising:
- first and second voltage terminals having voltages of different magnitudes
- each of said first and second conducting paths including first and second switches connected in series, with said first switch being connected electrically closer to said first voltage terminal than said second switch and the intersections of said first and second switches in each of said paths defining output electrodes across which pulse-generator output bi-phasic pulses are produced;
- interconnecting means for connecting said first switch of said first conducting path with said second switch of said second conducting path and said first switch of said second conducting path with said second switch of said first conducting path to respectively close and open said second switches in response to said first switches of opposite paths being opened and closed;
- a driving means for alternately driving one of said first switches open and the other closed for a first predetermined time period, and vice versa for a second predetermined time period.
- first and second voltage terminals having different voltage potentials thereon;
Abstract
A circuit for producing current-controlled bi-phasic pulses to stimulate living tissue includes two conducting paths connected in parallel between high and low voltage terminals, with each of the conducting paths having first and second switches connected in series therein. The intersections of the respective first and second switches in each of the paths define output terminals across which bi-phasic pulses are produced. These output terminals include electrode members for electrically attaching them to living tissues. Interconnecting circuits connect the first switch of each of the conducting paths with the second switch of the other conducting path to respectively open and close the second switches in response to the first switches of opposite paths being opened and closed. A digital programmer alternately drives one of the first switches open and the other closed. Current controlling valves are connected in the paths between the low voltage terminal and the output terminals to selectively control current flow through the electrodes.
Description
United States Patent 1191 Weiss Dec. 9, 1975 Bl-PHASIC CURRENT STIMULATION Primary ExaminerRichard A. Gaudet SYSTEM Assistant ExaminerLee S. Cohen [75] Inventor; Gerhard Weiss, Northford Conn. Attorney, Agent, or Firm-Walter Spruegel [73] Assignee: Axotronics lnc., Hamden, Conn.
[57] ABSTRACT [22] Filed: Aug. 19, 1974 A circuit for producing current-controlled bi-phasic [21] PP No: 498,740 pulses to stimulate living tissue includes two conducting paths connected in parallel between high and low 52 US. Cl 128/419 PG; 128/421 W terminals with each of the csnducting PathS 51 1m. (:1. A61N l/36 havmg first and seem! switches in Series 5 Field f Search 128/42O, 421, 422 423, therein. The intersections of the respective first and 128/419 13, 419 C 419 E 419 G, 419 PG, second switches in each of the paths define output ter- 9 R minals across which bi-phasic pulses are produced. These output terminals include electrode members for 5 References Cited electrically attaching therlrli tto living tissutes. lrgerfcolrlinectin circuits connectt e irst switch 0 eac 0 t e UNITED STATES PATENTS condu ting paths with the second switch of the other LaVCZZT) conducting to respectively open and close the 2 a 419 P6 second switches in response to the first switches of op- 3:727:616 41973 1.5112122: izizi i i: posite paths being operfed and closed A digital 3,835,865 9/1974 Bowers 128/419 PG gramme alternately dm'es one of the first swltches Canada 128/419 R open and the other closed. Current controlling valves are connected in the paths between the low voltage terminal and the output terminals to selectively control current flow through the electrodes.
7 Claims, 2 Drawing Figures US. Patent Dec. 9, 1975 & mama VQZMGE /-4 BI-PHASIC CURRENT STIMULATION SYSTEM BACKGROUND OF THE INVENTION This invention relates broadly to the art of electronic stimulators and more particularly to devices for generating current controlled, bi-phasic pulses to stimulate areas of the brain, nerves, or other organs.
In behavioral research, stimulation of certain areas of the brain is often used to find ways to suppress intractable pain, aggressive behavior, or toexplore brain structures and their influence on the behavior of animals or humans. Brain stimulation is also applied in efforts to fight other disorders associated with the brain.
In addition to brain research, electrical stimulation is also widely used to restore proper functioning of various organs such as hearts, lungs, or bladders in cases where the control of these organs is disturbed because of disease, injury, or other causes.
The effects elicited by electrical stimulations are, to a large extent, determined by the amounts of current flow rather than by the magnitudes of applied voltages. Since the impedance between points of stimulation varies widely and may even change during stimulation, the current will also change even if the voltage is maintained at a constant level. This makes it difficult to control the amount of current flow. Thus, it is an object of this invention to provide an electrical stimulation circuit which provides an adjustable, controllable, stimulating current.
Further, if pulses of one polarity only are used for stimulation, electro/chemical effects tend to create unfavorable interactions between electrodes and tissues. Many researchers, therefore, prefer stimulation pulses in both polarities, such as with a negative pulse, followed immediately by a positive pulse, preferably each being of equal magnitude and duration. Thus, it is an object of this invention to provide an electrical circuit for providing such pulses.
Another object of this invention is to provide a circuit for generating bi-phasic, current-controlled pulses with current amplitudes of both negative and positive portions thereof being proportional to an applied control voltage.
Still another object of this invention is to provide a current controlled, bi-phasic or mono-phasic pulse generator whose output impedance is high enough to allow the use of its stimulation electrodes for measuring the response to stimulation, e.g. brain stimulation, EEG recordings and the like.
Still another object of this invention is to provide a circuit for generating bi-phasic or mono-phasic current controlled pulses, the characteristics of which are controlled by a programmer.
SUMMARY OF THE INVENTION first switch of the first path is interconnected to the second switch of the second path, and vice versa, to assure that the first and second switches of opposite paths are opened and closed together. A driving device alternately drives the first switch of the first path on or closed," and the first switch of the second path off,
2 or open, and vice versa. The driving mechanism measures the time period that the switches are in open and closed positions, Electronic valves are located in each of the first and second paths between the first voltage terminal and the output terminals to selectively control current flow to the electrodes.
BRIEF DESCRIPTION OF THE DRAWINGS The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of a preferred embodiment of the invention, as illustrated in the accompanying drawings in which reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention in a clear manner.
FIG. 1 is a schematic diagram of a current controlled, bi-phasis pulse generator employing principles of this invention; and
FIG. 2 is a diagrammatic representation of an output pulse of the bi-phasic pulse generator of FIG. 1.
DESCRIPTION OF THE PREFERRED EMBODIMENT The preferred embodiment of the pulse generator of this invention, illustrated in FIG. 1, comprises two first transistor switches 10 and 12, two second transistor switches 14 'and 16, a pair of current control valve devices 18 and 20, a digital programmer 22 and a control voltage generator 24. The pulse generator is energized by a +20 volts, positive voltage terminal 26 and a -20 volts, negative voltage terminal 28 and forms two parallel connected, main conducting paths 30 and 32 between these voltage terminals. In practice, a single 40 volt source could be used.
The first transistor switches 10 and 12 comprise PNP transistors Q1 and Q2 and 22K control resistors 34 and 36. The second transistor switches 14 and 16 comprise NPN transistors Q3 and Q4 and K control resistors 38 and 40, In this regard, the interconnection between the positive voltage terminal 26 and the base of the transistor Q1 via the resistor 34 holds transistor O1 in an off state when transistor Q4 is off and no current can flow through resistor 40. When transistor O4 is on, a current path is established from the positive voltage terminal 26 through both the Q1 base-to-emitter junction, and the resistor 34, the resistor 40, and the transistor O4 to the negative voltage terminal 28, thereby placing transistor O1 in an on state. There is a similar interaction between the resistors 36 and 38 and the transistors Q2 and Q3.
The first and second current control valve devices 18 and 20 respectively comprise NPN transistors Q5 and Q6 and series resistors 42 and 44.
In the preferred embodiment, the switching transistors Q1, Q2, Q3, and Q4 are chosen to operate, for practical purposes, in an on-off fashion while the current control transistors Q5 and Q6 are chosen to operate in a gradual manner for regulating current flow.
In operation, the electrodes 46 and 48 are connected to living tissue, such as nerves or other organs, either directly or indirectly. When it is desired to transmit biphasic pulses to the living tissue, the digital programmer 22 gates the switching transistor Q3 on and the switching transistor Q4 off for a time period of T1 and then gates the switching transistor Q4 on and switching transistor Q3 off for an identical time period T2.
During time period Tl, when the switching transistor Q3 is on, a current flow is established through the control resistors 36 and 38 to lower the potential appearing at the base of the switching transistor Q2. This places the switching transistor Q2 in an on mode of operation. Thus, a circuit is established between the positive voltage terminal 26 and the first electrode 46 through the switching transistor Q2. A circuit is also completed between the second electrode 48 and the negative voltage terminal 28 via the current control transistor Q5, the resistor 42, and diode 50, and the switching transistor Q3. Thus, a circuit is completed from the positive voltage terminal 26 to the negative voltage terminal 28 via living tissue connected to the electrodes 46 and 48. It should be noted that during time period T, both of the switching transistors Q4 and Q1 are locked in off modes.
During the time period T2 the switching transistor Q3 is turned off so that the voltage appearing at the base of the switching transistor Q2 rises to the voltage of the positive voltage terminal 26, which, in turn, turns off the switching transistor Q2. Thus, the electrode 46 is no longer connected to the high voltage terminal 26. However, the switching transistor Q4 is turned on by the digital programmer 22 so that the voltage at the base of the switching transistor Q1 rises to turn on this transistor. Thus, the electrode 48 is now in communication with the positive voltage terminal 26. Also, the other electrode 46 is now in communication with the negative voltage terminal 28 via the second current control device 20, the diode 52 and the switching transistor Q4. Thus, the polarities, and current flow, of the electrodes 46 and 48 have been reversed.
Before and after the time periods T1 and T2, the digital programmer does not place either the third or fourth switching transistors Q3 and Q4 in on modes of operation so that neither of the electrodes 46 and 48 are connected to the positive and negative voltage terminals 26 and 28. The output signal appearing at electrodes 46 and 48 before, after, and during the time periods T1 and T2 can be graphically represented as shown in FIG. 2.
In the preferred embodiment, the control voltage generator 24 provides steady-state control voltages ranging from 1.4 to 5 volts. It should be understood that the magnitude of a selected control voltage determines the magnitudes of current signals applied by the electrodes 46 and 48 to living tissue.
It should be further appreciated that the duration of the pulses can be accurately controlled by the digital programmer 22.
In addition, during periods of no pulses, since all four transistor switches are open, the electrodes 46 and 48 can be used for recording purposes.
While the invention has been particularly shown and described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention. For example, various voltage magnitudes at voltage terminals 26 and 28 could be employed and it is not necessary that one of the supply voltages be either negative or positive. With regard to voltage magni tude, the high voltage source limit is determined by the perimeters of the transistors chosen and/or by the maximum current which has to be driven through the highest expected load impedance. Further, the transistors could be replaced by other types of electrical valves.
The embodiment of the invention in which an exclusive property or privilege are claimed are defined as follows:
1. A bi-phasic pulse generator for producing pulses to stimulate living tissue comprising:
first and second voltage terminals having voltages of different magnitudes;
first and second conducting paths connected in parallel between said first and second voltage terminals, each of said first and second conducting paths including first and second switches connected in series, with said first switch being connected electrically closer to said first voltage terminal than said second switch and the intersections of said first and second switches in each of said paths defining output electrodes across which pulse-generator output bi-phasic pulses are produced;
interconnecting means for connecting said first switch of said first conducting path with said second switch of said second conducting path and said first switch of said second conducting path with said second switch of said first conducting path to respectively close and open said second switches in response to said first switches of opposite paths being opened and closed; and,
a driving means for alternately driving one of said first switches open and the other closed for a first predetermined time period, and vice versa for a second predetermined time period.
2. A bi-phasic pulse generator as in claim 1 wherein is further included current-control, valve means connected in each of said paths between said first voltage terminal and said output electrodes to thereby control the flow of current through said electrodes.
3. A bi-phasic pulse generator as in claim 2, wherein said switches and control means comprise transistors.
4. A bi-phasic pulse generator as claimed in claim 1, wherein said driving means comprises a programming circuit means for alternately driving said first switches in a programmed sequence.
5. A bi-phasic pulse generator as claimed in claim 1, wherein said output electrodes include means for electrically attaching said electrodes to living tissue.
6. A bi-phasic pulse generator for producing pulses to stimulate living tissuecomprising:
first and second voltage terminals having different voltage potentials thereon;
of said electrodes including electronic valve means for selectively controlling the magnitude of current flow between said first voltage terminal and both of said first and second electrodes; and a control means attached to said electronic valve means for selectively adjusting the flow of current through said valve means. 7. A bi-phasic pulse generator as claimed in claim 6 wherein said electronic valve means comprise transistors.
Claims (7)
1. A bi-phasic pulse generator for producing pulses to stimulate living tissue comprising: first and second voltage terminals having voltages of different magnitudes; first and second conducting paths connected in parallel between said first and second voltage terminals, each of said first and second conducting paths including first and second switches connected in series, with said first switch being connected electrically closer to said first voltage terminal than said second switch and the intersections of said first and second switches in each of said paths defining output electrodes across which pulse-generator output bi-phasic pulses are produced; interconnecting means for connecting said first switch of said first conducting path with said second switch of said second conducting path and said first switch of said second conducting path with said second switch of said first conducting path to respectively close and open said second switches in response to said first switches of opposite paths being opened and closed; and, a driving means for alternately driving one of said first switches open and the other closed for a first predetermined time period, and vice versa for a second predetermined time period.
2. A bi-phasic pulse generator as in claim 1 wherein is further included current-control, valve means connected in each of said paths between said first voltage terminal and said output electrodes to thereby control the flow of current through said electrodes.
3. A bi-phasic pulse generator as in claim 2, wherein said switches and control means comprise transistors.
4. A bi-phasic pulse generator as claimed in claim 1, wherein said driving means comprises a programming circuit means for alternately driving said first switches in a programmed sequence.
5. A bi-phasic pulse generator as claimed in claim 1, wherein said output electrodes include means for electrically attaching said electrodes to living tissue.
6. A bi-phasic pulse generator for producing pulses to stimulate living tissue comprising: first and second voltage terminals having different voltage potentials thereon; first and second output electrodes adapted to be attached to living tissue; a control circuit means connected between each of said first and second voltage terminals and to each of said output electrodes for alternately connecting said first voltage terminal to said first electrode and said second voltage terminal to said second electrode and said first voltage terminal to said second electrode and said second voltage terminal to said first electrode, said control circuit means connected between said first voltage terminal and each of said electrodes including electronic valve means for selectively controlling the magnitude of current flow between said first voltage terminal and both of said first and second electrodes; and a control means attached to said electronic valve means for selectively adjusting the flow of current through said valve means.
7. A bi-phasic pulse gEnerator as claimed in claim 6 wherein said electronic valve means comprise transistors.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US498740A US3924641A (en) | 1974-08-19 | 1974-08-19 | Bi-phasic current stimulation system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US498740A US3924641A (en) | 1974-08-19 | 1974-08-19 | Bi-phasic current stimulation system |
Publications (1)
Publication Number | Publication Date |
---|---|
US3924641A true US3924641A (en) | 1975-12-09 |
Family
ID=23982312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US498740A Expired - Lifetime US3924641A (en) | 1974-08-19 | 1974-08-19 | Bi-phasic current stimulation system |
Country Status (1)
Country | Link |
---|---|
US (1) | US3924641A (en) |
Cited By (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4170999A (en) * | 1977-08-19 | 1979-10-16 | Biotronik Mess- Und Therapiegerate Gmbh & Co. | Demand pacer having reduced recovery time |
US4233965A (en) * | 1978-01-16 | 1980-11-18 | Cas Products, Inc. | Method and apparatus for the therapeutic treatment of living tissue |
US4327322A (en) * | 1980-10-06 | 1982-04-27 | Spatial Dynamics, Ltd. | Bidirectional current supply circuit |
EP0052247A2 (en) * | 1980-11-13 | 1982-05-26 | Torben Ejsing Dr. Jorgensen | Arrangement for the electrical stimulation of bones in the region of fracture |
US4343312A (en) * | 1979-04-16 | 1982-08-10 | Vitafin N.V. | Pacemaker output circuit |
US4373531A (en) * | 1979-04-16 | 1983-02-15 | Vitafin N.V. | Apparatus for physiological stimulation and detection of evoked response |
US4402322A (en) * | 1981-03-25 | 1983-09-06 | Medtronic, Inc. | Pacer output circuit |
US4446870A (en) * | 1978-03-16 | 1984-05-08 | Wing Thomas W | Electrical treatment method |
EP0154976A1 (en) * | 1984-03-12 | 1985-09-18 | BIO-RESEARCH ASSOCIATES, Inc. | Electrical muscle stimulator |
US4543956A (en) * | 1984-05-24 | 1985-10-01 | Cordis Corporation | Biphasic cardiac pacer |
US4561426A (en) * | 1984-02-29 | 1985-12-31 | Stewart David J | Magnetic biological device |
FR2586932A1 (en) * | 1985-09-12 | 1987-03-13 | Bertin & Cie | Device for electrical stimulation of biological tissues |
FR2587624A1 (en) * | 1985-09-26 | 1987-03-27 | Genin Jacques | Method and circuits for controlling implanted electrodes for neurophysiological stimulation |
US4726379A (en) * | 1985-11-14 | 1988-02-23 | Cardiac Control Systems, Inc. | Cardiac pacer with switching circuit for isolation |
US4800883A (en) * | 1986-04-02 | 1989-01-31 | Intermedics, Inc. | Apparatus for generating multiphasic defibrillation pulse waveform |
US4821723A (en) * | 1987-02-27 | 1989-04-18 | Intermedics Inc. | Biphasic waveforms for defibrillation |
US4846181A (en) * | 1987-10-02 | 1989-07-11 | Staodynamics, Inc. | Soft tissue wound healing therapy utilizing pulsed electrical stimulation |
US4926879A (en) * | 1988-06-13 | 1990-05-22 | Sevrain-Tech, Inc. | Electro-tactile stimulator |
US4958632A (en) * | 1978-07-20 | 1990-09-25 | Medtronic, Inc. | Adaptable, digital computer controlled cardiac pacemaker |
US5036850A (en) * | 1989-08-25 | 1991-08-06 | Staodyn, Inc. | Biphasic pulse output stage for electronic stimulating device |
US5069211A (en) * | 1989-08-25 | 1991-12-03 | Staodyn, Inc. | Microprocessor controlled electronic stimulating device having biphasic pulse output |
US5135478A (en) * | 1989-05-10 | 1992-08-04 | Drug Delivery Systems Inc. | Multi-signal electrical transdermal drug applicator |
US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
US5328452A (en) * | 1989-05-10 | 1994-07-12 | Drug Delivery Systems Inc. | Multi-signal electrical transdermal drug application |
US5330512A (en) * | 1992-12-28 | 1994-07-19 | Cardiac Pacemakers, Inc. | Electrode charge-neutral sensing of evoked ECG |
US5385575A (en) * | 1992-03-24 | 1995-01-31 | Angeion Corporation | Implantable cardioverter defibrillator having variable output capacitance |
US5411528A (en) * | 1992-11-19 | 1995-05-02 | Pacesetter, Inc. | Electrically programmable polarity connector for an implantable body tissue stimulator |
US5425748A (en) * | 1993-08-05 | 1995-06-20 | Ventritex, Inc. | Method and apparatus for cardiac defibrillation |
US5447518A (en) * | 1993-08-31 | 1995-09-05 | Ventritex, Inc. | Method and apparatus for phase related cardiac defibrillation |
US5456690A (en) * | 1993-05-20 | 1995-10-10 | Ventritex, Inc. | System and method for fractal pulse defibrillation |
US5507781A (en) * | 1991-05-23 | 1996-04-16 | Angeion Corporation | Implantable defibrillator system with capacitor switching circuitry |
US5833712A (en) * | 1991-05-23 | 1998-11-10 | Angeion Corporation | Implantable defibrillator system for generating a biphasic waveform |
US5871506A (en) * | 1996-08-19 | 1999-02-16 | Mower; Morton M. | Augmentation of electrical conduction and contractility by biphasic cardiac pacing |
WO1999044682A1 (en) * | 1998-03-05 | 1999-09-10 | Mower Morton M | System and method for multiple site biphasic stimulation to revert ventricular arrhythmias |
US6136019A (en) * | 1996-08-19 | 2000-10-24 | Mower Family Chf Treatment Irrevocable Trust | Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool |
US6141587A (en) * | 1996-08-19 | 2000-10-31 | Mower Family Chf Treatment Irrevocable Trust | Augmentation of muscle contractility by biphasic stimulation |
US6141586A (en) * | 1996-08-19 | 2000-10-31 | Mower Family Chf Treatment Irrevocable Trust | Method and apparatus to allow cyclic pacing at an average rate just above the intrinsic heart rate so as to maximize inotropic pacing effects at minimal heart rates |
US6178351B1 (en) | 1996-08-19 | 2001-01-23 | The Mower Family Chf Treatment Irrevocable Trust | Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation |
US6295470B1 (en) | 1996-08-19 | 2001-09-25 | The Mower Family Chf Treatment Irrevocable Trust | Antitachycardial pacing |
US6332096B1 (en) | 2000-02-16 | 2001-12-18 | Mower Chf Treatment Irrevocable Trust | Augmentation of electrical conduction and contractility by biphasic cardiac pacing |
US6337995B1 (en) | 1996-08-19 | 2002-01-08 | Mower Chf Treatment Irrevocable Trust | Atrial sensing and multiple site stimulation as intervention for atrial fibrillation |
US6341235B1 (en) | 1996-08-19 | 2002-01-22 | Mower Chf Treatment Irrevocable Trust | Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool |
US6343232B1 (en) | 1966-08-19 | 2002-01-29 | Mower Chf Treatment Irrevocable Trust | Augmentation of muscle contractility by biphasic stimulation |
US6411847B1 (en) | 1996-08-19 | 2002-06-25 | Morton M. Mower | Apparatus for applying cyclic pacing at an average rate just above the intrinsic heart rate |
US6411845B1 (en) | 1999-03-04 | 2002-06-25 | Mower Chf Treatment Irrevocable Trust | System for multiple site biphasic stimulation to revert ventricular arrhythmias |
US6458157B1 (en) * | 1997-08-04 | 2002-10-01 | Suaning Gregg Joergen | Retinal stimulator |
US20040153127A1 (en) * | 2003-01-15 | 2004-08-05 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ | Treatments for snoring using injectable neuromuscular stimulators |
US20040167589A1 (en) * | 2003-02-22 | 2004-08-26 | Chester Heath | Viral-inhibiting apparatus and methods |
US7020526B1 (en) | 2002-05-16 | 2006-03-28 | Ruan Jin Zhao | Electronic gastro-intestinal stimulation device |
US20060129208A1 (en) * | 2004-12-13 | 2006-06-15 | Link Yu | Full-range electrotherapy unit with digital force modulator |
US7203537B2 (en) | 1996-08-19 | 2007-04-10 | Mr3 Medical, Llc | System and method for breaking reentry circuits by cooling cardiac tissue |
US20070203528A1 (en) * | 2006-02-28 | 2007-08-30 | Vernon Scott D | Supply circuit for implantable medical devices |
US7440800B2 (en) | 1996-08-19 | 2008-10-21 | Mr3 Medical, Llc | System and method for managing detrimental cardiac remodeling |
US7840264B1 (en) | 1996-08-19 | 2010-11-23 | Mr3 Medical, Llc | System and method for breaking reentry circuits by cooling cardiac tissue |
US7908003B1 (en) | 1996-08-19 | 2011-03-15 | Mr3 Medical Llc | System and method for treating ischemia by improving cardiac efficiency |
US8019421B2 (en) | 1999-03-05 | 2011-09-13 | Metacure Limited | Blood glucose level control |
US8244371B2 (en) | 2005-03-18 | 2012-08-14 | Metacure Limited | Pancreas lead |
US8260416B2 (en) | 1996-01-08 | 2012-09-04 | Impulse Dynamics, N.V. | Electrical muscle controller |
US8326416B2 (en) | 2003-03-10 | 2012-12-04 | Impulse Dynamics Nv | Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue |
US8346363B2 (en) * | 1999-03-05 | 2013-01-01 | Metacure Limited | Blood glucose level control |
US8352031B2 (en) | 2004-03-10 | 2013-01-08 | Impulse Dynamics Nv | Protein activity modification |
US8447399B2 (en) | 1996-08-19 | 2013-05-21 | Mr3 Medical, Llc | System and method for managing detrimental cardiac remodeling |
US8548583B2 (en) | 2004-03-10 | 2013-10-01 | Impulse Dynamics Nv | Protein activity modification |
US8666495B2 (en) | 1999-03-05 | 2014-03-04 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US8700161B2 (en) | 1999-03-05 | 2014-04-15 | Metacure Limited | Blood glucose level control |
US8792985B2 (en) | 2003-07-21 | 2014-07-29 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US8825152B2 (en) | 1996-01-08 | 2014-09-02 | Impulse Dynamics, N.V. | Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue |
US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US9821158B2 (en) | 2005-02-17 | 2017-11-21 | Metacure Limited | Non-immediate effects of therapy |
US9931503B2 (en) | 2003-03-10 | 2018-04-03 | Impulse Dynamics Nv | Protein activity modification |
US10953234B2 (en) | 2015-08-26 | 2021-03-23 | Element Science, Inc. | Wearable devices |
US11185709B2 (en) | 2014-02-24 | 2021-11-30 | Element Science, Inc. | External defibrillator |
US11253715B2 (en) | 2018-10-10 | 2022-02-22 | Element Science, Inc. | Wearable medical device with disposable and reusable components |
US11911087B2 (en) | 2020-08-07 | 2024-02-27 | Biosig Technologies, Inc. | Controlled switching network for electrophysiology procedures |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3523539A (en) * | 1968-02-26 | 1970-08-11 | Hewlett Packard Co | Demand cardiac pacemaker and method |
US3563247A (en) * | 1968-03-14 | 1971-02-16 | Gen Electric | Bidirectional heart stimulator |
US3589370A (en) * | 1967-06-09 | 1971-06-29 | Medical Biolog Instrumentation | Electronic muscle stimulator |
US3727616A (en) * | 1971-06-15 | 1973-04-17 | Gen Dynamics Corp | Electronic system for the stimulation of biological systems |
US3835865A (en) * | 1970-07-10 | 1974-09-17 | Gen Electric | Body organ stimulator |
-
1974
- 1974-08-19 US US498740A patent/US3924641A/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3589370A (en) * | 1967-06-09 | 1971-06-29 | Medical Biolog Instrumentation | Electronic muscle stimulator |
US3523539A (en) * | 1968-02-26 | 1970-08-11 | Hewlett Packard Co | Demand cardiac pacemaker and method |
US3563247A (en) * | 1968-03-14 | 1971-02-16 | Gen Electric | Bidirectional heart stimulator |
US3835865A (en) * | 1970-07-10 | 1974-09-17 | Gen Electric | Body organ stimulator |
US3727616A (en) * | 1971-06-15 | 1973-04-17 | Gen Dynamics Corp | Electronic system for the stimulation of biological systems |
Cited By (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6343232B1 (en) | 1966-08-19 | 2002-01-29 | Mower Chf Treatment Irrevocable Trust | Augmentation of muscle contractility by biphasic stimulation |
US4170999A (en) * | 1977-08-19 | 1979-10-16 | Biotronik Mess- Und Therapiegerate Gmbh & Co. | Demand pacer having reduced recovery time |
US4233965A (en) * | 1978-01-16 | 1980-11-18 | Cas Products, Inc. | Method and apparatus for the therapeutic treatment of living tissue |
US4446870A (en) * | 1978-03-16 | 1984-05-08 | Wing Thomas W | Electrical treatment method |
US5318593A (en) * | 1978-07-20 | 1994-06-07 | Medtronic, Inc. | Multi-mode adaptable implantable pacemaker |
US4958632A (en) * | 1978-07-20 | 1990-09-25 | Medtronic, Inc. | Adaptable, digital computer controlled cardiac pacemaker |
US4343312A (en) * | 1979-04-16 | 1982-08-10 | Vitafin N.V. | Pacemaker output circuit |
US4373531A (en) * | 1979-04-16 | 1983-02-15 | Vitafin N.V. | Apparatus for physiological stimulation and detection of evoked response |
US4327322A (en) * | 1980-10-06 | 1982-04-27 | Spatial Dynamics, Ltd. | Bidirectional current supply circuit |
EP0052247A2 (en) * | 1980-11-13 | 1982-05-26 | Torben Ejsing Dr. Jorgensen | Arrangement for the electrical stimulation of bones in the region of fracture |
EP0052247A3 (en) * | 1980-11-13 | 1982-09-15 | Torben Ejsing Dr. Jorgensen | Arrangement for the electrical stimulation of bones |
US4402322A (en) * | 1981-03-25 | 1983-09-06 | Medtronic, Inc. | Pacer output circuit |
US4561426A (en) * | 1984-02-29 | 1985-12-31 | Stewart David J | Magnetic biological device |
EP0154976A1 (en) * | 1984-03-12 | 1985-09-18 | BIO-RESEARCH ASSOCIATES, Inc. | Electrical muscle stimulator |
US4543956A (en) * | 1984-05-24 | 1985-10-01 | Cordis Corporation | Biphasic cardiac pacer |
FR2586932A1 (en) * | 1985-09-12 | 1987-03-13 | Bertin & Cie | Device for electrical stimulation of biological tissues |
FR2587624A1 (en) * | 1985-09-26 | 1987-03-27 | Genin Jacques | Method and circuits for controlling implanted electrodes for neurophysiological stimulation |
US4726379A (en) * | 1985-11-14 | 1988-02-23 | Cardiac Control Systems, Inc. | Cardiac pacer with switching circuit for isolation |
US4800883A (en) * | 1986-04-02 | 1989-01-31 | Intermedics, Inc. | Apparatus for generating multiphasic defibrillation pulse waveform |
US4821723A (en) * | 1987-02-27 | 1989-04-18 | Intermedics Inc. | Biphasic waveforms for defibrillation |
US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
US4846181A (en) * | 1987-10-02 | 1989-07-11 | Staodynamics, Inc. | Soft tissue wound healing therapy utilizing pulsed electrical stimulation |
US4926879A (en) * | 1988-06-13 | 1990-05-22 | Sevrain-Tech, Inc. | Electro-tactile stimulator |
US5135478A (en) * | 1989-05-10 | 1992-08-04 | Drug Delivery Systems Inc. | Multi-signal electrical transdermal drug applicator |
US5328452A (en) * | 1989-05-10 | 1994-07-12 | Drug Delivery Systems Inc. | Multi-signal electrical transdermal drug application |
US5036850A (en) * | 1989-08-25 | 1991-08-06 | Staodyn, Inc. | Biphasic pulse output stage for electronic stimulating device |
US5069211A (en) * | 1989-08-25 | 1991-12-03 | Staodyn, Inc. | Microprocessor controlled electronic stimulating device having biphasic pulse output |
US5833712A (en) * | 1991-05-23 | 1998-11-10 | Angeion Corporation | Implantable defibrillator system for generating a biphasic waveform |
US5507781A (en) * | 1991-05-23 | 1996-04-16 | Angeion Corporation | Implantable defibrillator system with capacitor switching circuitry |
US5385575A (en) * | 1992-03-24 | 1995-01-31 | Angeion Corporation | Implantable cardioverter defibrillator having variable output capacitance |
US5411528A (en) * | 1992-11-19 | 1995-05-02 | Pacesetter, Inc. | Electrically programmable polarity connector for an implantable body tissue stimulator |
US5330512A (en) * | 1992-12-28 | 1994-07-19 | Cardiac Pacemakers, Inc. | Electrode charge-neutral sensing of evoked ECG |
US5456690A (en) * | 1993-05-20 | 1995-10-10 | Ventritex, Inc. | System and method for fractal pulse defibrillation |
US5425748A (en) * | 1993-08-05 | 1995-06-20 | Ventritex, Inc. | Method and apparatus for cardiac defibrillation |
US5447518A (en) * | 1993-08-31 | 1995-09-05 | Ventritex, Inc. | Method and apparatus for phase related cardiac defibrillation |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US8825152B2 (en) | 1996-01-08 | 2014-09-02 | Impulse Dynamics, N.V. | Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue |
US8311629B2 (en) | 1996-01-08 | 2012-11-13 | Impulse Dynamics, N.V. | Electrical muscle controller |
US8301247B2 (en) | 1996-01-08 | 2012-10-30 | Impulse Dynamics, N.V. | Electrical muscle controller |
US8260416B2 (en) | 1996-01-08 | 2012-09-04 | Impulse Dynamics, N.V. | Electrical muscle controller |
US6337995B1 (en) | 1996-08-19 | 2002-01-08 | Mower Chf Treatment Irrevocable Trust | Atrial sensing and multiple site stimulation as intervention for atrial fibrillation |
US8447399B2 (en) | 1996-08-19 | 2013-05-21 | Mr3 Medical, Llc | System and method for managing detrimental cardiac remodeling |
US5871506A (en) * | 1996-08-19 | 1999-02-16 | Mower; Morton M. | Augmentation of electrical conduction and contractility by biphasic cardiac pacing |
US6178351B1 (en) | 1996-08-19 | 2001-01-23 | The Mower Family Chf Treatment Irrevocable Trust | Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation |
US6341235B1 (en) | 1996-08-19 | 2002-01-22 | Mower Chf Treatment Irrevocable Trust | Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool |
US6141586A (en) * | 1996-08-19 | 2000-10-31 | Mower Family Chf Treatment Irrevocable Trust | Method and apparatus to allow cyclic pacing at an average rate just above the intrinsic heart rate so as to maximize inotropic pacing effects at minimal heart rates |
US6411847B1 (en) | 1996-08-19 | 2002-06-25 | Morton M. Mower | Apparatus for applying cyclic pacing at an average rate just above the intrinsic heart rate |
US7840264B1 (en) | 1996-08-19 | 2010-11-23 | Mr3 Medical, Llc | System and method for breaking reentry circuits by cooling cardiac tissue |
US20020099413A1 (en) * | 1996-08-19 | 2002-07-25 | Mower Morton M. | Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool |
US7908003B1 (en) | 1996-08-19 | 2011-03-15 | Mr3 Medical Llc | System and method for treating ischemia by improving cardiac efficiency |
US6295470B1 (en) | 1996-08-19 | 2001-09-25 | The Mower Family Chf Treatment Irrevocable Trust | Antitachycardial pacing |
US7440800B2 (en) | 1996-08-19 | 2008-10-21 | Mr3 Medical, Llc | System and method for managing detrimental cardiac remodeling |
US6141587A (en) * | 1996-08-19 | 2000-10-31 | Mower Family Chf Treatment Irrevocable Trust | Augmentation of muscle contractility by biphasic stimulation |
US6895274B2 (en) | 1996-08-19 | 2005-05-17 | The Mower Family Chf Treatment Irrevocable Trust | Antitachycardial pacing |
US7203537B2 (en) | 1996-08-19 | 2007-04-10 | Mr3 Medical, Llc | System and method for breaking reentry circuits by cooling cardiac tissue |
US6136019A (en) * | 1996-08-19 | 2000-10-24 | Mower Family Chf Treatment Irrevocable Trust | Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool |
US8290585B2 (en) | 1996-08-19 | 2012-10-16 | Mr3 Medical, Llc | Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool |
US6458157B1 (en) * | 1997-08-04 | 2002-10-01 | Suaning Gregg Joergen | Retinal stimulator |
EP1064048B1 (en) * | 1998-01-16 | 2004-10-20 | Morton M. Mower | Augmentation of electrical conduction and contractibility by biphasic cardiac pacing administered via the cardiac blood pool |
US6067470A (en) * | 1998-03-05 | 2000-05-23 | Mower Family Chf Treatment Irrevocable Trust | System and method for multiple site biphasic stimulation to revert ventricular arrhythmias |
WO1999044682A1 (en) * | 1998-03-05 | 1999-09-10 | Mower Morton M | System and method for multiple site biphasic stimulation to revert ventricular arrhythmias |
US6411845B1 (en) | 1999-03-04 | 2002-06-25 | Mower Chf Treatment Irrevocable Trust | System for multiple site biphasic stimulation to revert ventricular arrhythmias |
US8019421B2 (en) | 1999-03-05 | 2011-09-13 | Metacure Limited | Blood glucose level control |
US8346363B2 (en) * | 1999-03-05 | 2013-01-01 | Metacure Limited | Blood glucose level control |
US8700161B2 (en) | 1999-03-05 | 2014-04-15 | Metacure Limited | Blood glucose level control |
US8666495B2 (en) | 1999-03-05 | 2014-03-04 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
US6332096B1 (en) | 2000-02-16 | 2001-12-18 | Mower Chf Treatment Irrevocable Trust | Augmentation of electrical conduction and contractility by biphasic cardiac pacing |
US7020526B1 (en) | 2002-05-16 | 2006-03-28 | Ruan Jin Zhao | Electronic gastro-intestinal stimulation device |
US7277749B2 (en) | 2003-01-15 | 2007-10-02 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Treatments for snoring using injectable neuromuscular stimulators |
US20040153127A1 (en) * | 2003-01-15 | 2004-08-05 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ | Treatments for snoring using injectable neuromuscular stimulators |
US20070073372A1 (en) * | 2003-02-22 | 2007-03-29 | Chester Heath | Viral-inhibiting apparatus and methods |
US20040167589A1 (en) * | 2003-02-22 | 2004-08-26 | Chester Heath | Viral-inhibiting apparatus and methods |
US7228184B2 (en) * | 2003-02-22 | 2007-06-05 | Chester Heath | Viral-inhibiting method |
US8326416B2 (en) | 2003-03-10 | 2012-12-04 | Impulse Dynamics Nv | Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue |
US9931503B2 (en) | 2003-03-10 | 2018-04-03 | Impulse Dynamics Nv | Protein activity modification |
US8792985B2 (en) | 2003-07-21 | 2014-07-29 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US8352031B2 (en) | 2004-03-10 | 2013-01-08 | Impulse Dynamics Nv | Protein activity modification |
US8548583B2 (en) | 2004-03-10 | 2013-10-01 | Impulse Dynamics Nv | Protein activity modification |
US20060129208A1 (en) * | 2004-12-13 | 2006-06-15 | Link Yu | Full-range electrotherapy unit with digital force modulator |
US7209782B2 (en) * | 2004-12-13 | 2007-04-24 | Link Yu | Full-range electrotherapy unit with digital force modutator |
US9821158B2 (en) | 2005-02-17 | 2017-11-21 | Metacure Limited | Non-immediate effects of therapy |
US8244371B2 (en) | 2005-03-18 | 2012-08-14 | Metacure Limited | Pancreas lead |
US20070203528A1 (en) * | 2006-02-28 | 2007-08-30 | Vernon Scott D | Supply circuit for implantable medical devices |
US7852052B2 (en) | 2006-02-28 | 2010-12-14 | Medtronic, Inc. | Supply circuit for implantable medical devices |
US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
US11185709B2 (en) | 2014-02-24 | 2021-11-30 | Element Science, Inc. | External defibrillator |
US10953234B2 (en) | 2015-08-26 | 2021-03-23 | Element Science, Inc. | Wearable devices |
US11701521B2 (en) | 2015-08-26 | 2023-07-18 | Element Science, Inc. | Wearable devices |
US11253715B2 (en) | 2018-10-10 | 2022-02-22 | Element Science, Inc. | Wearable medical device with disposable and reusable components |
US11911087B2 (en) | 2020-08-07 | 2024-02-27 | Biosig Technologies, Inc. | Controlled switching network for electrophysiology procedures |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3924641A (en) | Bi-phasic current stimulation system | |
US3311111A (en) | Controllable electric body tissue stimulators | |
US4340062A (en) | Body stimulator having selectable stimulation energy levels | |
US4327322A (en) | Bidirectional current supply circuit | |
US3851651A (en) | Facial stimulating apparatus having sequentially energized electrodes | |
US4528984A (en) | Autoprogrammable functional electrical stimulation apparatus and method | |
EP0160753B1 (en) | Electrotherapy acupuncture apparatus and method | |
US3645267A (en) | Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate | |
US4019510A (en) | Therapeutic method of using low intensity direct current generator with polarity reversal | |
US3983881A (en) | Muscle stimulator | |
US6128531A (en) | Delivery of ICD shock capacitor energy via a controlled current source | |
AU4183489A (en) | Method and device for generating electric pulses intended to stimulate biological objects | |
JP2001509037A (en) | Output stage with switchable constant voltage and constant current modes | |
SE9602846D0 (en) | A stimulation device | |
US5131389A (en) | Electrostimulating device | |
US3517663A (en) | Threshold analyzer for an implanted heart stimulator | |
US3757795A (en) | Power supply and voltage double output circuitry for implantable electro-medical apparatus | |
US3797500A (en) | Mandible stimulator | |
US3769986A (en) | Body organ threshold analyzer | |
US3295528A (en) | Electrical therapeutic equipment | |
DE2133743A1 (en) | Electric organ stimulator | |
CA2006631C (en) | Bio stimulating device | |
US4173741A (en) | Pulse generator | |
GB1479734A (en) | Electromedical apparatus | |
Lin et al. | Feasibility study of the engineering problems in a multi-electrode visual cortex stimulation system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: VENTRITEX, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:AXOTRONICS, INC., A CORP. OF CT.;REEL/FRAME:005289/0451 Effective date: 19900420 |